CN110882344A - Traditional Chinese medicine formula for treating throat itching and cough and preparation method thereof - Google Patents
Traditional Chinese medicine formula for treating throat itching and cough and preparation method thereof Download PDFInfo
- Publication number
- CN110882344A CN110882344A CN201911382157.4A CN201911382157A CN110882344A CN 110882344 A CN110882344 A CN 110882344A CN 201911382157 A CN201911382157 A CN 201911382157A CN 110882344 A CN110882344 A CN 110882344A
- Authority
- CN
- China
- Prior art keywords
- parts
- cough
- bulbus fritillariae
- fritillariae cirrhosae
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010011224 Cough Diseases 0.000 title claims abstract description 82
- 208000003251 Pruritus Diseases 0.000 title claims abstract description 44
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 230000007803 itching Effects 0.000 title claims description 22
- 210000003800 pharynx Anatomy 0.000 claims abstract description 44
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000000706 filtrate Substances 0.000 claims description 16
- 239000006187 pill Substances 0.000 claims description 16
- 244000144725 Amygdalus communis Species 0.000 claims description 15
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 15
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 15
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 15
- 235000017443 Hedysarum boreale Nutrition 0.000 claims description 15
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims description 15
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 15
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 15
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 15
- 240000006079 Schisandra chinensis Species 0.000 claims description 15
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 15
- 235000020224 almond Nutrition 0.000 claims description 15
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 15
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 14
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 11
- 238000007605 air drying Methods 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 8
- 238000000227 grinding Methods 0.000 claims description 8
- 238000007873 sieving Methods 0.000 claims description 8
- 238000002791 soaking Methods 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- 238000009455 aseptic packaging Methods 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 26
- 239000000796 flavoring agent Substances 0.000 abstract description 8
- 235000019634 flavors Nutrition 0.000 abstract description 8
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 7
- 230000007774 longterm Effects 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 2
- 210000004072 lung Anatomy 0.000 description 28
- 206010062717 Increased upper airway secretion Diseases 0.000 description 18
- 208000026435 phlegm Diseases 0.000 description 18
- 210000000952 spleen Anatomy 0.000 description 16
- 210000002784 stomach Anatomy 0.000 description 14
- 230000008506 pathogenesis Effects 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 241000700159 Rattus Species 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 208000006673 asthma Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 8
- 230000010412 perfusion Effects 0.000 description 8
- 208000000059 Dyspnea Diseases 0.000 description 7
- 206010013975 Dyspnoeas Diseases 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 201000007100 Pharyngitis Diseases 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 208000017574 dry cough Diseases 0.000 description 6
- 238000003304 gavage Methods 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000037396 body weight Effects 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 4
- 230000008595 infiltration Effects 0.000 description 4
- 238000001764 infiltration Methods 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000000621 bronchi Anatomy 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000012154 double-distilled water Substances 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000004969 inflammatory cell Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000003285 pharmacodynamic effect Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 241000675108 Citrus tangerina Species 0.000 description 2
- 206010013789 Dry throat Diseases 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 108090000174 Interleukin-10 Proteins 0.000 description 2
- 108090000978 Interleukin-4 Proteins 0.000 description 2
- 108010002616 Interleukin-5 Proteins 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000009589 pathological growth Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 230000002110 toxicologic effect Effects 0.000 description 2
- 231100000027 toxicology Toxicity 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000090 Abdominal rigidity Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241001481833 Coryphaena hippurus Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000935235 Fritillaria meleagris Species 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- -1 Glycyrrhiza polysaccharide Chemical class 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000570 acute poisoning Toxicity 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000037883 airway inflammation Diseases 0.000 description 1
- 150000003797 alkaloid derivatives Chemical group 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229960003408 cefazolin sodium Drugs 0.000 description 1
- FLKYBGKDCCEQQM-WYUVZMMLSA-M cefazolin sodium Chemical compound [Na+].S1C(C)=NN=C1SCC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 FLKYBGKDCCEQQM-WYUVZMMLSA-M 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000027498 hoarse voice Diseases 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001965 increasing effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000001543 purgative effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229960000329 ribavirin Drugs 0.000 description 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine formula for treating pharynx itch and cough and a preparation method thereof. The traditional Chinese medicine formula is prepared from the following raw material components: the material is prepared from the following raw materials: fructus Schisandrae chinensis, Bulbus Fritillariae Cirrhosae, ramulus Cinnamomi, semen Armeniacae amarum, pericarpium Citri Tangerinae, herba Menthae, and radix Glycyrrhizae Preparata. The traditional Chinese medicine formula for treating the pharynx itch cough is simple in medicine flavor, easy to absorb, simple to process and easy to popularize, and has both short-term curative effect and long-term curative effect on the pharynx itch cough.
Description
[ technical field ] A method for producing a semiconductor device
The invention relates to the field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine formula for treating pharynx itch and cough and a preparation method thereof.
[ background of the invention ]
The cough with throat itching is different from the common cough and is characterized in that the cough is caused by itching, the throat itching is caused by the cough, the cough is firstly followed by the throat itching, and the cough is reduced after the cough; cough is manifested as paroxysmal cough, even spasmodic cough, or accompanied by dry throat, pharyngalgia, or hoarse voice, no or little phlegm, sticky phlegm, and brings great trouble to life, work and study.
At present, the treatment for the pharynx itch and cough is mainly based on the medication. Western medicines are most commonly used for treating leukotriene drugs and antihistamines, and have obvious short-term effect, but are easy to cause immune disorder and drug dependence problems after being treated, so that the control effect of long-term symptoms is not ideal. The recent treatment by adopting traditional Chinese medicines has certain advantages, the pharynx itch cough belongs to the categories of wind cough, pharyngitis and the like in the traditional Chinese medicine, the symptoms are caused by the interaction of internal deficiency and external evil, the pathogenesis mainly refers to spleen qi deficiency, lung and kidney yin deficiency and external infection wind evil, and the pathogenesis and clinical manifestation of the cough are different from those of the common cough. However, the traditional Chinese medicine formula for treating the cough with the throat itching focuses on the pathogenesis of the intermingled phlegm and heat, and ignores the pathogenesis of the deficiency of the spleen, the lung and the kidney and the external wind evil to a certain extent, so that the commonly used heat-clearing, phlegm-reducing and cough-relieving medicines have unsatisfactory effects on treating the cough with the throat itching.
In addition, some traditional Chinese medicine formulas for throat itching and cough have more medicine flavor and higher medicine cost, or part of the components have low bioavailability and are difficult to absorb; and the processing technology of the traditional Chinese medicine prescription components aiming at the symptoms of throat itching and cough is complicated, time-consuming and labor-consuming, and causes certain difficulty in popularization and application.
Therefore, aiming at the treatment of the cough with the throat itching, the pathogenesis needs to be comprehensively mastered, the pathogenesis of the deficiency of the spleen and the lung and the exogenous wind pathogen needs to be considered, and the pathogenesis of the exogenous wind pathogen also needs to be considered, so that the short-term curative effect and the long-term curative effect can be ensured to be considered in the treatment of the cough with the throat itching; the problems of easy absorption, simple processing and easy popularization need to be considered in the aspect of dosage form selection.
[ summary of the invention ]
The invention aims to: aiming at the defects of the prior art, the traditional Chinese medicine formula for treating the cough with the throat itching and the preparation method thereof are provided, the traditional Chinese medicine formula for treating the cough with the throat itching is simple in medicine flavor, easy to absorb, simple to process and easy to popularize, and both short-term curative effect and long-term curative effect are achieved in the aspect of treating the cough with the throat itching.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
a traditional Chinese medicine formula for treating pharynx itch and cough is prepared from the following raw material components: fructus Schisandrae chinensis, Bulbus Fritillariae Cirrhosae, ramulus Cinnamomi, semen Armeniacae amarum, pericarpium Citri Tangerinae, herba Menthae, and radix Glycyrrhizae Preparata.
Further, the feed additive is prepared from the following raw material components in parts by weight: 14-16 parts of schisandra chinensis, 12-14 parts of bulbus fritilariae, 4-6 parts of cassia twig, 8-10 parts of almond, 3-5 parts of dried orange peel, 3-5 parts of mint and 1-3 parts of honey-fried licorice root.
Preferably, the feed is prepared from the following raw material components in parts by weight: 15 parts of schisandra chinensis, 13 parts of bulbus fritillariae cirrhosae, 5 parts of cassia twig, 9 parts of almond, 4 parts of pericarpium citri reticulatae, 4 parts of mint and 2 parts of honey-fried licorice root.
The preparation method of the traditional Chinese medicine formula for treating pharynx itch and cough comprises the following steps: (1) soaking 6 Chinese medicinal materials including fructus Schisandrae chinensis, ramulus Cinnamomi, semen Armeniacae amarum, pericarpium Citri Tangerinae, herba Menthae and radix Glycyrrhizae Preparata in clear water in casserole for 15-20 min, heating to boil, decocting with slow fire for 30-40 min, and filtering; adding appropriate amount of water into the residue, decocting with slow fire for 30-40 min, filtering, and mixing the filtrates;
(2) cleaning Bulbus Fritillariae Cirrhosae, air drying, crushing, grinding into fine powder, and sieving with 600-mesh and 800-mesh sieve to obtain Bulbus Fritillariae Cirrhosae powder;
(3) adding the bulbus fritillariae cirrhosae powder obtained in the step (2) into the filtrate obtained in the step (1), and concentrating to the relative density of 1.20-1.40 to obtain the bulbus fritillariae cirrhosae powder.
The invention also provides a preparation method of another traditional Chinese medicine formula for treating pharynx itch and cough, which comprises the following steps: (1) soaking 6 Chinese medicinal materials including fructus Schisandrae chinensis, ramulus Cinnamomi, semen Armeniacae amarum, pericarpium Citri Tangerinae, herba Menthae and radix Glycyrrhizae Preparata in clear water in casserole for 15-20 min, heating to boil, decocting with slow fire for 30-40 min, and filtering; adding appropriate amount of water into the residue, decocting with slow fire for 30-40 min, filtering, and mixing the filtrates;
(2) cleaning Bulbus Fritillariae Cirrhosae, air drying, crushing, grinding into fine powder, and sieving with 600-mesh and 800-mesh sieve to obtain Bulbus Fritillariae Cirrhosae powder;
(3) adding the bulbus fritillariae cirrhosae powder obtained in the step (2) into the filtrate obtained in the step (1), concentrating until the relative density is 1.20-1.40, adding honey, uniformly mixing, preparing into concentrated pills, and carrying out aseptic packaging to obtain the bulbus fritillariae cirrhosae powder. The drug effects of the medicines in the formula are as follows:
schisandra chinensis: the five herbs are salty in flavor and enter heart, lung and kidney meridians. Sour-salty food enters liver to tonify kidney, pungent food enters heart to tonify lung, sweet food enters middle energizer to benefit spleen and stomach. The functional indications are as follows: astringe lung to stop cough, nourish essence, check diarrhea and stop sweating. "Wu Wei Zi is the essential cough herb recorded in materia medica original prescription, and is used for cough due to wind-cold, summer-heat, dryness, fatigue, kidney-water, kidney-fire, chronic cough, dyspnea and dyspnea.
Tendril-leaved fritillary bulb: cool in nature, sweet and neutral. Enter lung and stomach meridians. The functional indications are as follows: moisten lung to arrest cough, resolve phlegm and relieve asthma. It can be used for treating cough with excessive phlegm and dry throat; cough due to wind; cough and dyspnea in children; swelling of sore throat; pulmonary abscess and pulmonary impotence. The record of Shennong Ben Cao Jing records that the medicine is mainly used for treating typhoid fever, dysphoria, stranguria, pathogenic factors, hernia, pharyngitis, difficult milk, incised wound and wind spasm.
Cassia twig: pungent, sweet and warm. Enter lung, kidney, heart and bladder meridians. The functional indications are as follows: tonify kidney yang, activate blood and warm spleen and stomach. It is indicated for kidney yang deficiency, decline of vital gate fire, cold limbs and pulse, cold pain in abdomen, cold arthralgia and lumbago. The record of Shennong Ben Cao Jing records that the cassia twig, pungent and warm in flavor, governs the adverse rise of qi, stagnates qi and is blocked in the throat, vomits and absorbs, benefits the joints, tonifies middle-jiao and tonifies qi.
Almond: bitter in property and slightly warm in nature. Enter lung and large intestine meridians. The functional indications are as follows: dispel phlegm and relieve cough, relieve dyspnea, moisten intestines. It is indicated for cough due to exogenous pathogenic factor, dyspnea, throat impediment, constipation due to intestinal dryness. The book records that the cough is mainly coughing, the upper qi is thunder and ringing, the throat is blocked, the lower qi is downward, breast is produced, golden sores are caused, and the cold heart runs to the dolphin. Recorded in Yunnan materia Medica, the traditional Chinese medicine is used for stopping cough, eliminating phlegm, moistening lung, moistening intestines and stomach, eliminating flour accumulation, descending qi and treating infantile malnutrition.
Dried orange peel: pungent, bitter and warm. Enter lung, spleen and stomach meridians. The functional indications are as follows: dry dampness, resolve phlegm, regulate qi and strengthen spleen, regulate middle energizer. It is indicated for cough, dyspnea, abdominal distention or pain, dyspepsia, chest distress, abdominal distention, anorexia, loose stool, poor appetite, vomiting and diarrhea. The book of Ben Cao Hui Yan records that the flavor is pungent and good in property, so it can open the breath; the stomach is bitter and purgative, so it can remove phlegm; it is mild in temperature and good at dredging, so it can stop vomiting, relieve cough, strengthen spleen and harmonize stomach. Recorded in the book of the daily herbal medicine, "can dispel the pathogenic energy and purge, warm and tonify, eliminate diaphragm qi, resolve phlegm and saliva, harmonize spleen to relieve cough, and treat five stranguria".
Mint: cool in nature and pungent in flavor. Enter lung and liver meridians. Has effects of relieving sore throat, promoting eruption, clearing away wind-heat, dispersing stagnated liver qi, and activating qi-flowing. It is used to treat common cold, early stage of wind-heat, headache, measles, pharyngitis, aphtha, rubella, conjunctival congestion, and chest and hypochondrium distention.
Honey-fried licorice root: sweet and neutral. Enter lung, spleen, stomach and heart meridians. The functional indications are as follows: invigorating spleen and replenishing qi, moistening lung for arresting cough, clearing heat and detoxicating, relieving pain, and alleviating drug property. It is used to treat weakness of spleen and stomach, shortness of breath, hypodynamia, palpitation, cough, excessive phlegm, toxic heat, sore and ulcer, abdominal pain, spasm and pain of limbs.
Modern pharmacological studies show that the schisandra chinensis can effectively inhibit macrophage and neutrophil infiltration of lung tissues, regulate the expression of inflammatory factors and have good relieving effect on airway inflammation and cough and asthma.
The bulbus fritilariae is contained in a plurality of traditional Chinese medicine formulas or traditional Chinese medicine preparations for treating acute tracheitis, bronchitis and other diseases, the total alkaloid part of the bulbus fritilariae has obvious or very obvious cough relieving effect on the cough caused by the ammonia water of mice, has repairing effect on the pathological damage of the trachea of acute bronchitis animals and has inhibiting effect on the cough caused by the ammonia water and citric acid.
The ramulus Cinnamomi contains chemical components such as cinnamaldehyde, cinnamic acid, cinnamyl alcohol, protocatechuic acid, etc., and has pharmacological activities of resisting virus, resisting bacteria, reducing blood sugar, relieving fever, resisting inflammation, resisting allergy, resisting blood coagulation, resisting tumor, tranquilizing, resisting anxiety, lowering blood pressure, dilating blood vessel, protecting nerve, etc. Can be used for treating various diseases.
Amygdalin contained in almond is decomposed in human body to generate a trace amount of hydrocyanic acid, the hydrocyanic acid can inhibit respiratory center to make respiratory movement smooth, thereby having the effect of relieving cough and asthma.
The tangerine peel contains volatile oil, has irritation, has the effect of eliminating phlegm and facilitating expectoration, the tangerine peel decoction has weak expansion effect on bronchus, and the alcohol extract has high asthma relieving potency and strong anti-inflammatory effect.
The herba Menthae contains volatile oil, and the oil mainly contains menthol, menthone and menthyl esters. Has obvious cough relieving, inflammation diminishing and bacteriostasis effects on the upper respiratory tract infection.
Radix Glycyrrhizae Preparata contains glycyrrhizin, glycyrrhetinic acid, and Glycyrrhiza polysaccharide, and has antiinflammatory and antiallergic effects.
It has antiinflammatory and antiallergic effects, and can protect the inflamed throat and trachea mucosa of respiratory system. Has effects of repairing gastrointestinal mucosa and relieving spasm of smooth muscle of stomach and intestine. Simultaneously has tranquilizing, immunoregulating, immunity regulating, antitumor and analgesic effects.
In summary, due to the adoption of the technical scheme, the invention has the beneficial effects that:
(1) the invention sets up a prescription aiming at the etiology of 'external infection wind evil' of the pharynx itch cough and the pathogenesis of 'spleen-lung-kidney deficiency', has mild and lasting drug property and no side effect, considers short-term curative effect and long-term curative effect on the treatment of the pharynx itch cough, has simple prescription drug taste, easy absorption and simple processing, and is easy to carry and take after being processed into pills.
In the formula, the schisandra chinensis is sour and salty and enters the liver to tonify the kidney, pungent and bitter to enter the heart to tonify the lung, sweet to enter the middle uterus to strengthen the spleen and stomach; ramulus Cinnamomi is pungent, sweet and warm, and enters lung, kidney, heart and bladder meridians; the almond has bitter and slightly warm properties, enters lung and large intestine channels, and has the efficacies of warming yang, reducing phlegm, relieving cough and asthma. Pericarpium Citri Tangerinae, pungent, bitter and warm, enters lung, spleen and stomach meridians; prepared licorice root, radix Glycyrrhizae Praeparata, sweet and neutral, enters lung, spleen, stomach and heart meridians, and dried orange peel and prepared licorice root are used together to dispel phlegm, relieve spasm, relieve cough and asthma. Bulbus Fritillariae Cirrhosae is cool in nature, sweet and neutral, and enters lung and stomach meridians; the mint is cool in nature and pungent in flavor, enters lung and liver meridians, and is combined with the bulbus fritilariae and the mint to strengthen the effects of moistening lung, reducing phlegm, soothing wind and dissipating heat. The formula aims at the etiology of 'external infection wind evil' of pharynx itch and cough and the pathogenesis of 'spleen-lung-kidney deficiency', and achieves the comprehensive efficacies of relieving sore throat, relieving itching, relieving cough, reducing phlegm and relieving asthma by comprehensively grasping the etiology and pathogenesis and combining the medicines. Embodies the theoretical characteristics and treatment characteristics of syndrome differentiation treatment and integral treatment of the traditional Chinese medicine.
(2) Animal experiments prove that the formula has remarkable curative effect on pharynx itch and cough.
[ description of the drawings ]
FIG. 1 is a graph showing morphological changes of lung tissues in each group in example 5 of the present invention. Wherein, A is a control group; b, model group; c, low dose group; d, medium dose group; e high dose group
[ detailed description ] embodiments
Example 1
Prescription: 15 parts of schisandra chinensis, 13 parts of bulbus fritillariae cirrhosae, 5 parts of cassia twig, 9 parts of almond, 4 parts of pericarpium citri reticulatae, 4 parts of mint and 2 parts of honey-fried licorice root.
The preparation method comprises the following steps:
(1) 6 traditional Chinese medicines of schisandra chinensis, cassia twig, almond, dried orange peel, mint and honey-fried licorice root are placed in a marmite clear water for soaking for 18 minutes, then heated to boiling, decocted for 35 minutes by slow fire and filtered; adding appropriate amount of water into the residue, decocting with slow fire for 35 min, filtering, and mixing the filtrates;
(2) cleaning Bulbus Fritillariae Cirrhosae, air drying, crushing, grinding into fine powder, and sieving with 600 mesh sieve to obtain Bulbus Fritillariae Cirrhosae powder;
(3) and (3) adding the bulbus fritillariae cirrhosae powder obtained in the step (2) into the filtrate obtained in the step (1), and concentrating to the relative density of 1.30 to obtain the bulbus fritillariae cirrhosae powder.
Example 2
Prescription: 14 parts of schisandra chinensis, 14 parts of bulbus fritillariae cirrhosae, 4 parts of cassia twig, 10 parts of almond, 3 parts of pericarpium citri reticulatae, 5 parts of mint and 1 part of honey-fried licorice root.
The preparation method comprises the following steps:
(1) 6 traditional Chinese medicines of schisandra chinensis, cassia twig, almond, dried orange peel, mint and honey-fried licorice root are placed in a marmite clear water for soaking for 15 minutes, then heated to boiling, decocted for 30 minutes by slow fire and filtered; adding appropriate amount of water into the residue, decocting with slow fire for 40 min, filtering, and mixing the filtrates;
(2) cleaning Bulbus Fritillariae Cirrhosae, air drying, crushing, grinding into fine powder, and sieving with 800 mesh sieve to obtain Bulbus Fritillariae Cirrhosae powder;
(3) and (3) adding the bulbus fritillariae cirrhosae powder obtained in the step (2) into the filtrate obtained in the step (1), and concentrating to the relative density of 1.20 to obtain the bulbus fritillariae cirrhosae powder.
Example 3
Prescription: 16 parts of schisandra chinensis, 12 parts of bulbus fritillariae cirrhosae, 6 parts of cassia twig, 8 parts of almond, 5 parts of pericarpium citri reticulatae, 3 parts of mint and 3 parts of honey-fried licorice root.
The preparation method comprises the following steps:
(1) 6 traditional Chinese medicines of schisandra chinensis, cassia twig, almond, dried orange peel, mint and honey-fried licorice root are placed in a marmite clear water for soaking for 20 minutes, then heated to boiling, decocted for 40 minutes by slow fire and filtered; adding appropriate amount of water into the residue, decocting with slow fire for 30 min, filtering, and mixing the filtrates;
(2) cleaning Bulbus Fritillariae Cirrhosae, air drying, crushing, grinding into fine powder, and sieving with 600 mesh sieve to obtain Bulbus Fritillariae Cirrhosae powder;
(3) and (3) adding the bulbus fritillariae cirrhosae powder obtained in the step (2) into the filtrate obtained in the step (1), and concentrating to the relative density of 1.40 to obtain the bulbus fritillariae cirrhosae powder.
Example 4
Prescription: 15 parts of schisandra chinensis, 13 parts of bulbus fritillariae cirrhosae, 5 parts of cassia twig, 9 parts of almond, 4 parts of pericarpium citri reticulatae, 4 parts of mint and 2 parts of honey-fried licorice root.
The preparation method comprises the following steps:
(1) 6 traditional Chinese medicines of schisandra chinensis, cassia twig, almond, dried orange peel, mint and honey-fried licorice root are placed in a marmite clear water for soaking for 18 minutes, then heated to boiling, decocted for 35 minutes by slow fire and filtered; adding appropriate amount of water into the residue, decocting with slow fire for 35 min, filtering, and mixing the filtrates;
(2) cleaning Bulbus Fritillariae Cirrhosae, air drying, crushing, grinding into fine powder, and sieving with 600 mesh sieve to obtain Bulbus Fritillariae Cirrhosae powder;
(3) adding the bulbus fritillariae cirrhosae powder obtained in the step (2) into the filtrate obtained in the step (1), concentrating to the relative density of 1.30, adding honey, uniformly mixing, preparing into concentrated pills, 6 g of each pill, and carrying out aseptic packaging to obtain the bulbus fritillariae cirrhosae powder.
Remarking: the "parts" numbers described in the above examples are all referred to as "parts by weight".
To demonstrate the therapeutic effect of the Chinese medicinal formulation of the present invention, the applicant conducted the following toxicological and pharmacodynamic experiments.
EXAMPLE 5 exemplary toxicological, pharmacodynamic and clinical treatment of the Chinese medicinal formulation of the present invention
1. Toxicology test of animals
(1) Acute poisoning test for animals
① test animals SPF BALB/c mice 100, half male and half female, body weight (20 + -2 g).
② test method comprises adding appropriate amount of double distilled water into pill, stirring, heating in water bath to obtain 20% Chinese medicinal liquid, intragastrically administering 20g/kg of body weight to mice with tolerance 100 times of clinical patients, slightly increasing activity of mice after administration for 35 min, recovering to normal after about 1 hr, continuously observing for 7 days, and administering via intragastrically administering to mice to achieve the effects of normal activity, normal diet, water intake, defecation and weight increase.
(2) Long term toxicity test in animals
① test animals SPF Wistar rat 90, male and female half, body weight (160 + -15 g).
② the test method comprises dividing rats into 3 groups of formula gavage administration low dose group (short for low dose group), formula gavage administration medium dose group (short for medium dose group), and formula gavage administration high dose group (short for high dose group), wherein each group contains 30 rats, adding appropriate amount of double distilled water into formula pill, stirring uniformly, heating in water bath to obtain 20% concentration Chinese medicinal liquid, wherein the unit weight gavage administration amounts of low dose, medium dose, and high dose group are respectively 0.5, 2, and 5 times of the equivalent dosage of clinical patients, performing continuous gavage administration for 180 days, performing blood biochemical detection on the rats, killing the rats after gavage, and performing blood biochemical detection on the rats, wherein the detection indexes comprise ALT activity, AST activity, Serum Creatinine (SCR), serum urea nitrogen (BUN), and urine creatinine (UCr), performing morphological observation on the rats by HE staining on liver and kidney tissue, taking 30 rats as normal control group, comparing the results of normal blood perfusion, and performing pathological observation on the rats, and comparing the results of the pathological blood biochemical observation and the pathological growth and the control group, and the pathological growth and the results of the rats.
2. Pharmacodynamic test of animals
① test animals, SPF class Kunming mice 50, half male and half female, body weight (18 + -2 g).
② test method comprises dividing mice into normal control group (for short, control group), pharynx itch cough animal model group (for short, model group), formula gastric perfusion administration low dose group (for short, low dose group), formula gastric perfusion administration medium dose group (for short, medium dose group), and formula gastric perfusion administration high dose group (for short, high dose group) 5 groups, each group containing 10 mice, performing asthma molding for the model groups, low dose, medium dose, and high dose groups, establishing pharynx itch cough mice model by ovalbumin intraperitoneal injection sensitization and atomization inhalation excitation method, adding appropriate amount of double distilled water into the formula pill, stirring uniformly, heating in water bath to obtain 20% concentration of Chinese medicinal liquid, and performing oral perfusion administration for low dose, medium dose, and high dose groups with unit weight gastric perfusion administration amounts respectively equal to 0.5, 2, 5 times of clinical patient equivalent amount, performing oral perfusion administration for the control group and the model group with physiological saline, performing continuous oral perfusion administration for 4 weeks, performing oral perfusion administration for the mice to detect immunoglobulin uk, and obtaining immunoglobulin and inflammation related to lung inflammation (Interleukin 4-10 IL 5, Interleukin-5-10-volume observation of lung tissue change, and IL-5-volume observation.
③ test results, wherein the results of statistical analysis show that each dose group has different degree of improvement on IgE, IL-4, IL-5 and IL-10 water average, approaches the level of the control group, and has statistical significance compared with the model group, the morphological observation result shows that the control group has clear bronchus and lung tissues, smooth tube wall, no blood vessel congestion and inflammatory cell infiltration, the model group has unclear bronchus and lung tissue structure, unsmooth tube wall and large inflammatory cell infiltration, each dose group has less alveolar exudate and lighter inflammatory cell infiltration degree, and has obvious improvement compared with the model group (the experimental results are shown in Table 1 and figure 1)
Note: comparison with model groups:ΔP<0.05,ΔΔP<0.01. comparison with the control group:*P<0.05,**P<0.01。
the formulation pellets used in this example were prepared from example 4.
3. Typical case of clinical treatment
(1) Old, female, 62 years old. The cough due to throat itching is aggravated by repeated attack for 2 years and the diagnosis is aggravated for 1 week. The patients have throat itching and dry cough after cold 1 month ago, the patients often feel dry mouth and polydipsia, and take the medicines of 'cough quick-stop, acute bronchitis syrup' and the like, and the cefazolin sodium and the ribavirin are dripped for a while, but the throat itching and the dry cough are not obviously relieved, and the patients are in treatment before. The patients have paroxysmal pharynx itch, dry cough without phlegm and dry mouth. No obvious abnormal change of chest film, red tongue with thin coating, and thready and rapid pulse. The four diagnostic methods are combined to differentiate the syndrome as "cough with wind type with throat itching". The pill with the formula is taken 6 pills (6 g per pill) every day, 2 times a day in the morning and evening, 3 pills are taken with warm boiled water each time, 7 days are 1 treatment course, after continuously taking for 4 treatment courses, symptoms of pharynx itch and dry cough disappear, symptoms of dry mouth and polydipsia are obviously relieved, and no relapse occurs after 1 year of follow-up visit.
(2) Lie, male, 9 years old. The patients have an electric fan after bathing for 7 days, and then have throat itching and dry cough, and the local clinic oral administration of the anti-inflammatory drug and the cough syrup has no obvious improvement on the treatment. Through the four diagnostic methods, the syndrome differentiation is "Houbi" (spleen deficiency with wind type) in TCM. The pill with the formula is taken 6 pills (6 g per pill) every day, 2 times a day in the morning and evening, 3 pills are taken with warm boiled water each time, 7 days are 1 course of treatment, 1 course of treatment is taken, after the course of treatment is finished, symptoms of pharynx itch and dry cough disappear, and no recurrence is seen in half a year after follow-up.
The above description is intended to describe in detail the preferred embodiments of the present invention, but the embodiments are not intended to limit the scope of the claims of the present invention, and all equivalent changes and modifications made within the technical spirit of the present invention should fall within the scope of the claims of the present invention.
Claims (5)
1. The traditional Chinese medicine formula for treating throat itching and cough is characterized by being prepared from the following raw material components: fructus Schisandrae chinensis, Bulbus Fritillariae Cirrhosae, ramulus Cinnamomi, semen Armeniacae amarum, pericarpium Citri Tangerinae, herba Menthae, and radix Glycyrrhizae Preparata.
2. The traditional Chinese medicine formula for treating pharynx itch and cough according to claim 1, is characterized by being prepared from the following raw material components in parts by weight: 14-16 parts of schisandra chinensis, 12-14 parts of bulbus fritilariae, 4-6 parts of cassia twig, 8-10 parts of almond, 3-5 parts of dried orange peel, 3-5 parts of mint and 1-3 parts of honey-fried licorice root.
3. The traditional Chinese medicine formula for treating pharynx itch and cough according to claim 2, which is characterized by being prepared from the following raw material components in parts by weight: 15 parts of schisandra chinensis, 13 parts of bulbus fritillariae cirrhosae, 5 parts of cassia twig, 9 parts of almond, 4 parts of pericarpium citri reticulatae, 4 parts of mint and 2 parts of honey-fried licorice root.
4. The preparation method of the traditional Chinese medicine formula for treating pharynx itch and cough as claimed in any one of claims 1 to 3, characterized by comprising the following steps: (1) soaking 6 Chinese medicinal materials including fructus Schisandrae chinensis, ramulus Cinnamomi, semen Armeniacae amarum, pericarpium Citri Tangerinae, herba Menthae and radix Glycyrrhizae Preparata in clear water in casserole for 15-20 min, heating to boil, decocting with slow fire for 30-40 min, and filtering; adding appropriate amount of water into the residue, decocting with slow fire for 30-40 min, filtering, and mixing the filtrates;
(2) cleaning Bulbus Fritillariae Cirrhosae, air drying, crushing, grinding into fine powder, and sieving with 600-mesh and 800-mesh sieve to obtain Bulbus Fritillariae Cirrhosae powder;
(3) adding the bulbus fritillariae cirrhosae powder obtained in the step (2) into the filtrate obtained in the step (1), and concentrating to the relative density of 1.20-1.40 to obtain the bulbus fritillariae cirrhosae powder.
5. The method for preparing a traditional Chinese medicine formula for treating pharynx itch and cough according to claim 4, is characterized by comprising the following steps: (1) soaking 6 Chinese medicinal materials including fructus Schisandrae chinensis, ramulus Cinnamomi, semen Armeniacae amarum, pericarpium Citri Tangerinae, herba Menthae and radix Glycyrrhizae Preparata in clear water in casserole for 15-20 min, heating to boil, decocting with slow fire for 30-40 min, and filtering; adding appropriate amount of water into the residue, decocting with slow fire for 30-40 min, filtering, and mixing the filtrates;
(2) cleaning Bulbus Fritillariae Cirrhosae, air drying, crushing, grinding into fine powder, and sieving with 600-mesh and 800-mesh sieve to obtain Bulbus Fritillariae Cirrhosae powder;
(3) adding the bulbus fritillariae cirrhosae powder obtained in the step (2) into the filtrate obtained in the step (1), concentrating until the relative density is 1.20-1.40, adding honey, uniformly mixing, preparing into concentrated pills, and carrying out aseptic packaging to obtain the bulbus fritillariae cirrhosae powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911382157.4A CN110882344A (en) | 2019-12-27 | 2019-12-27 | Traditional Chinese medicine formula for treating throat itching and cough and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911382157.4A CN110882344A (en) | 2019-12-27 | 2019-12-27 | Traditional Chinese medicine formula for treating throat itching and cough and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110882344A true CN110882344A (en) | 2020-03-17 |
Family
ID=69753365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911382157.4A Pending CN110882344A (en) | 2019-12-27 | 2019-12-27 | Traditional Chinese medicine formula for treating throat itching and cough and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110882344A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1313110A (en) * | 2000-03-10 | 2001-09-19 | 刘明智 | Liquid coughremedy |
CN1692835A (en) * | 2004-05-03 | 2005-11-09 | 冯恩平 | Beverage with functions of relieving-cough and toning-lungs |
CN101396544A (en) * | 2007-09-26 | 2009-04-01 | 北京亚东生物制药有限公司 | Traditional Chinese medicine composition capable of ventilating the lung and relieving asthma and preparation and quality control method thereof |
CN102988712A (en) * | 2012-10-26 | 2013-03-27 | 吴玥霖 | Traditional Chinese medicine for treating cough and preparation method of traditional Chinese medicine |
CN104337999A (en) * | 2013-07-29 | 2015-02-11 | 刘笛 | Medicine with lung-moistening cough-relieving efficacy and good mouthfeel and application thereof |
CN109316583A (en) * | 2017-07-31 | 2019-02-12 | 李华 | Treat the prescription for swallowing cough of itching |
-
2019
- 2019-12-27 CN CN201911382157.4A patent/CN110882344A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1313110A (en) * | 2000-03-10 | 2001-09-19 | 刘明智 | Liquid coughremedy |
CN1692835A (en) * | 2004-05-03 | 2005-11-09 | 冯恩平 | Beverage with functions of relieving-cough and toning-lungs |
CN101396544A (en) * | 2007-09-26 | 2009-04-01 | 北京亚东生物制药有限公司 | Traditional Chinese medicine composition capable of ventilating the lung and relieving asthma and preparation and quality control method thereof |
CN102988712A (en) * | 2012-10-26 | 2013-03-27 | 吴玥霖 | Traditional Chinese medicine for treating cough and preparation method of traditional Chinese medicine |
CN104337999A (en) * | 2013-07-29 | 2015-02-11 | 刘笛 | Medicine with lung-moistening cough-relieving efficacy and good mouthfeel and application thereof |
CN109316583A (en) * | 2017-07-31 | 2019-02-12 | 李华 | Treat the prescription for swallowing cough of itching |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111214566A (en) | Epidemic prevention traditional Chinese medicine composition and preparation method and application thereof | |
CN103961614B (en) | Chinese medicine composition for treating respiratory disease and its production and use | |
CN104940485A (en) | Traditional Chinese medicine composition for treating infantile asthma and preparation method thereof | |
CN114748603B (en) | Pharmaceutical composition for preventing and treating new coronavirus pneumonia from changing or restoring yang and application thereof | |
CN101327293B (en) | Capsules for treating peptic ulcer and preparation method thereof | |
CN110882344A (en) | Traditional Chinese medicine formula for treating throat itching and cough and preparation method thereof | |
CN107753664B (en) | Traditional Chinese medicine composition for treating allergic rhinitis and preparation method thereof | |
CN105396017A (en) | Traditional Chinese medicine preparation used for treating fatty liver, and preparation method thereof | |
CN105106634A (en) | Traditional Chinese medicine preparation for treating acute appendicitis and application thereof | |
CN111084878A (en) | Biological medicine and medical total nutrient food for lung and respiratory system diseases and preparation method thereof | |
CN115212269B (en) | Traditional Chinese medicine compound composition for preventing and treating upper respiratory tract infection and preparation method and application thereof | |
CN107362311B (en) | Medicine 'Baicheqingjin' for treating cough | |
CN109481662B (en) | Stomach-nourishing soup containing rhizoma polygonati, radix ophiopogonis and radix ophiopogonis | |
CN1225266A (en) | Liquid medicine for treating cold | |
CN105168860A (en) | Traditional Chinese medicine composite for treating infantile asthma and preparation method thereof | |
CN105031492A (en) | Chinese drugs preparation for curing malaria and preparation method for Chinese drugs preparation | |
CN118044611A (en) | Lung-clearing and lung-protecting nutrition product | |
CN104906352A (en) | Traditional Chinese medicine liquid for treating deficiency-fire flaring-up type infantile oral ulcer and preparation method thereof | |
CN117942372A (en) | Traditional Chinese medicine preparation for treating rhinitis and pharyngitis of respiratory system | |
CN115779023A (en) | Traditional Chinese medicine composition for treating stomachache and preparation method and application thereof | |
CN116850258A (en) | Chinese medicinal composition with antiemetic effect and preparation method thereof | |
CN110946935A (en) | Formula for treating multiple myeloma complicated with renal failure | |
CN116173150A (en) | Traditional Chinese medicine preparation for treating anxiety and preparation method thereof | |
CN102335327B (en) | Pharmaceutical composition for treating asthma | |
CN114869987A (en) | A Chinese medicinal composition for preventing and treating hepatocarcinoma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |